Skip to main content
. 2024 Apr 11;4(4):e0002703. doi: 10.1371/journal.pgph.0002703

Fig 2. Recorded adverse events in each study arm.

Fig 2

Distribution of participants experiencing adverse events (pain, headache, tenderness, weakness, nausea, diarrhea, cough, myalgia, swelling, chills, loss of taste, redness, loss of smell or fever) recorded 1 week post booster vaccination in each study arm.